logo
  

Edwards Lifesciences Corp. (EW) Has Risen To A New High After Upgrade

RBC Capital Markets upgraded its rating on shares of Edwards Lifesciences Corp. (EW) Monday morning to "Outperform" from "Equal weight."

Edwards Lifesciences has gapped open sharply higher this morning and is now up 4.21 at $151.37. The stock has broken out of a 3-week trading range and has set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
RELATED NEWS
Follow RTT